Fact CheckerSign in

NCT07773064Recruiting

Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules

Source: ClinicalTrials.gov · Last updated 20 Aug 2026

Brief summary (registry, in English)

This ambidirectional observational cohort study builds upon and expands an existing coronary artery disease (CAD) cohort based on retinal fundus imaging (ChiCTR2200066429). A comprehensive baseline database will be established, including demographic characteristics, laboratory test results, coronary angiography findings, quantitative retinal vascular features, and multi-omics data.Artificial intelligence methods will be used to quantify retinal vascular characteristics and to develop and validate models for identifying and predicting CAD. In addition, targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays will be developed to measure previously identified CAD-related biomarkers, including metabolites and lipids, in baseline biological samples. Clinical, retinal imaging, and multi-omics data will subsequently be integrated to develop a risk stratification model for identifying individuals at high risk of CAD. Participants will be followed for cardiovascular events to evaluate the predictive performance of the model. The findings may support the development of improved strategies for CAD detection, risk assessment, and clinical management. No treatment or clinical intervention is assigned by the study protocol, and all medical decisions are made as part of routine clinical care.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
12 Aug 2026
Start date
14 May 2024
Primary completion date
31 Dec 2026
Lead sponsor
Beijing Hospital
NCT number
NCT07773064

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 14 May 2024 to the primary completion date, 31 Dec 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of heart transplantation or other solid-organ transplantation
  • History of severe congenital heart disease, valvular heart disease, myocardial disease, pericardial disease, or aortic dissection
  • Progressive life-threatening disease
  • History of alcohol or drug abuse
  • Current treatment for a psychiatric disorder
  • Current receipt of radiotherapy or chemotherapy for a malignant tumor
  • Acute or chronic infectious disease
  • Severe hepatic insufficiency, renal insufficiency, thyroid disease and autoimmune disease
  • Ophthalmic diseases affecting the retinal vasculature or optic disc structure, including retinal artery occlusion, retinal vein occlusion, glaucoma, or congenital optic disc abnormalities

Lab values

  • Severe heart failure, defined as New York Heart Association (NYHA) functional class IV or left ventricular ejection fraction (LVEF) ≤20%

Other

  • Pregnancy, breastfeeding, or plans to become pregnant during the study period
  • Life expectancy of less than 5 years
  • Color fundus photographs of insufficient quality because of severe ocular media opacity

Who the study is looking for

  • Older than 18 years
  • Symptoms suggestive of myocardial ischemia or the presence of multiple cardiovascular disease risk factors
  • Underwent coronary angiography during hospitalization
  • Underwent blood sample collection during hospitalization
  • Underwent bilateral color fundus photography during hospitalization
  • Availability of complete clinical data

Age in the registry: 18 years to 100 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beijing Friendship Hospital, Capital Medical University
Coordinator of this site? Confirm its status
BeijingChinaNot yet recruiting
Beijing Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Haidian Hospital
Coordinator of this site? Confirm its status
BeijingChinaCompleted

This page is information, not medical advice. Discuss any trial with your doctor.